ZuhreNTutuncuMD

PubMed

• 120 citations
  Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controll...
  C Antoni, Arthur Kavanaugh, Désirée van der Heijde, A. Beutler, Gregory F. Keenan, B. Zhou, B. Kirkham, Zuhre Tutuncu, Gerd R Burmester, Udo Schneider, Daniel E. Furst...> ;The Journal of Rheumatology. 2008 May 1
• 14 citations
  Are new agents used to treat rheumatoid arthritis safe to take during pregnancy?: Organization of Teratology Information Specialists (OTIS) study
  Christina D. Chambers, Gideon Koren, Zuhre Tutuncu, Diana Johnson, Kenneth L. Jones> ;Canadian Family Physician Medecin De Famille Canadien. 2007 Mar 1
• 45 citations
  Rheumatic disease in the elderly: rheumatoid arthritis.
  Zuhre Tutuncu, Arthur Kavanaugh> ;Rheumatic Diseases Clinics of North America. 2007 Feb 1
• 118 citations
  The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.
  Sarah Cassell, Jeffry D. Bieber, Phoebe Rich, Zuhre Tutuncu, Susan J. Lee, Kenneth C. Kalunian, Christopher W. Wu, Arthur Kavanaugh> ;The Journal of Rheumatology. 2007 Jan 1
• 130 citations
  Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?
  Zuhre Tutuncu, George W. Reed, Joel M. Kremer, Arthur Kavanaugh> ;Annals of the Rheumatic Diseases. 2006 Sep 1
• 29 citations
  Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
  Arthur Kavanaugh, Zuhre Tutuncu, Teresa Catalan-Sanchez> ;Current Opinion in Rheumatology. 2006 Jul 1
• 63 citations
  Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data
  Christina D. Chambers, Zuhre Tutuncu, Diana Johnson, Kenneth L. Jones> ;Arthritis Research & Therapy. 2006 Jun 14
• 4 citations
  A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.
  Mark C. Genovese, Eliza F. Chakravarty, David L. Boyle, Zuhre Tutuncu, Christine M Thorburn, Merita Halilhodzic, Stewart Kroll, Jan Baughman, Stanford J. Stewart, Arth...> ;The Journal of Rheumatology. 2005 Dec 1
• 99 citations
  Fcγ receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor α–blocking agents
  Zuhre Tutuncu, Arthur Kavanaugh, Nathan J. Zvaifler, Maripat Corr, Reena Deutsch, David L. Boyle> ;Arthritis and Rheumatism. 2005 Sep 1
• 15 citations
  Rheumatic disease in the elderly: rheumatoid arthritis.
  Zuhre Tutuncu, Arthur Kavanaugh> ;Clinics in Geriatric Medicine. 2005 Aug 1
• 483 citations
  Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arth...
  C Antoni, Arthur Kavanaugh, B. Kirkham, Zuhre Tutuncu, Gerd R Burmester, Udo Schneider, Daniel E. Furst, Jerry A. Molitor, Edward C. Keystone, Dafna D. Gladman, Bernha...> ;Arthritis and Rheumatism. 2005 Apr 1
• 1 citations
  Disease measures in evaluating the effect of anti-TNF therapy and predicting clinical outcome
  Z Tutuncu, C Bansal, A. Kavanaugh> ;Rheumatology. 2004 May 1
• Anti-TNF therapy for other inflammatory conditions.
  Tutuncu, Z., Morgan, G. J., Kavanaugh, A.> ;Clin Exp Rheumatol. 2002 Dec 05
• Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.
  Tutuncu, Z. N., Bilgie, A., Kennedy, L. G., Calin, A.> ;Ann Rheum Dis. 1994 Jun
• Join now to see all